Medicine and Dentistry
Ovarian Cancer
100%
Malignant Neoplasm
75%
Neoplasm
69%
Uterine Cancer
47%
Krukenberg Tumor
45%
Gynecological Oncology
43%
Diseases
41%
Cervical Cancer
38%
Cancer
35%
Female Genital Tract Cancer
28%
Overall Survival
26%
Oncology
25%
Wart Virus
25%
Recurrent Disease
23%
Cancer Cell
22%
Cervical Cancer Screening
19%
Quality of Life
16%
Breast Cancer
15%
Cross Sectional Study
15%
Progression Free Survival
15%
Carboplatin
15%
Natural Killer Cell
14%
Cancer Therapy
14%
Endometrium Carcinoma
14%
Paclitaxel
13%
Hysterectomy
13%
Biological Marker
13%
COVID-19
13%
Pelvis
13%
Radiation Therapy
12%
Cytotechnology
12%
Metastatic Carcinoma
11%
Melanoma
11%
Retroperitoneal Lymph Node Dissection
11%
Health Care Cost
9%
Laparotomy
9%
Immunohistochemistry
9%
Infection
9%
Adjuvant Therapy
9%
Carcinosarcoma
9%
In Vitro
9%
Immunotherapy
8%
Randomized Controlled Trial
8%
Clear Cell
8%
Papanicolaou Stain
8%
Cervix
8%
Squamous Cell Carcinoma
8%
Ovarian Tumor
8%
Patient Referral
8%
Carcinoma
7%
Colposcopy
7%
Laparoscopic Surgery
7%
Hazard Ratio
7%
Arm
7%
Odds Ratio
7%
Cancer Diagnosis
7%
Prevalence
7%
Adenocarcinoma
7%
Lymph Node
7%
CA-125
6%
Targeted Therapy
6%
Cancer Risk
6%
Cisplatin
6%
Xenograft
6%
Gene Expression
6%
Oncologist
6%
Cervical Intraepithelial Neoplasia
6%
Adjuvant Chemotherapy
6%
Clinician
6%
Sun Exposure
6%
Primary Tumor
6%
Surgeon
6%
DNA Mismatch Repair
6%
Kaplan Meier Method
6%
Gynecology
5%
Drug Resistance
5%
Wound
5%
Cytoreductive Surgery
5%
Papillomavirus Infection
5%
Primary Health Care
5%
Vulva
5%
Clear Cell Carcinoma
5%
Minimal Residual Disease
5%
Pandemic
5%
Phase II Trials
5%
Cell Line
5%
Reproductive Public Health
5%
Neuropathy
5%
Uterine Cervix Cytology
5%
Proteasome
5%
Health Care
5%
Vulvar Cancer
5%
Uterine Cervix Carcinoma
5%
Human Immunodeficiency Virus
5%
Prospective Cohort Study
5%
Keyphrases
Ovarian Cancer
79%
Tumor
49%
Endometrial Cancer
37%
Chemotherapy
32%
Whole Genome
30%
Cervical Cancer
29%
Gynecologic Oncology Group
28%
Natural Killer Cells
27%
Pan-cancer Analysis
26%
Epithelial Ovarian Cancer
25%
Cervical Cancer Screening
24%
Overall Survival
23%
In Cancer
22%
Paclitaxel
20%
Gynecological Cancer
20%
Gynecologic Oncology
19%
NRG Oncology
19%
Ovarian Cancer Cells
19%
Human Cancer
17%
High-risk Human Papillomavirus (HR-HPV)
17%
Confidence Interval
16%
Group Studies
15%
Carboplatin
15%
Advanced Ovarian Cancer
14%
United States
14%
Phase II Trial
13%
Progression-free Survival
13%
Gynecologic Cancer Survivors
13%
Gynecologic Malignancies
13%
Ovarian Cancer Patients
13%
COVID-19
12%
Cancer Patients
12%
Endometrioid
11%
Laparotomy
11%
High Risk
11%
Colorectal Cancer
11%
Cancer Treatment
10%
Molecular Characterization
10%
Endometrial Carcinoma
10%
Cervical Carcinoma
10%
High-grade Serous Ovarian Cancer (HGSOC)
10%
Young Women
10%
Ovarian Carcinoma
9%
Quality of Life
9%
Cancer Care
9%
COVID-19 Pandemic
9%
Adjuvant Therapy
9%
Cancer Types
8%
Sleeping Beauty Transposon
8%
Cancer Cells
8%
Tumor Subtype
8%
Immunohistochemistry
8%
Human Papillomavirus Testing
8%
Breast Cancer
8%
Tunneling Nanotubes
7%
Oncology Patients
7%
Overexpression
7%
Healthcare Professionals
7%
Colposcopy
7%
Deubiquitinating Enzyme
7%
Radiation Therapy
7%
Survivors
7%
Risk Factors
7%
Odds Ratio
7%
Recurrent Ovarian Cancer
7%
Hysterectomy
7%
Cancer Genome
7%
Randomized Controlled Trial
7%
Platinum-based Chemotherapy
6%
Carbohydrate Antigen 125 (CA125)
6%
Vulvar Squamous Cell Carcinoma
6%
Targeted Therapy
6%
Human Epidermal Growth Factor Receptor 2 (HER2)
6%
Cervical Cancer Prevention
6%
Uterine Serous Carcinoma
6%
Uterus
6%
Invasive Cervical Cancer
6%
Tumor Microenvironment
6%
Cisplatin
6%
Advanced Stage
6%
Adjuvant Chemotherapy
6%
Ubiquitin-proteasome System
6%
Minnesota
6%
Vulvar Cancer
6%
Clinical Outcomes
6%
Transposon
6%
T Cells
6%
Gene Signature
6%
Sleeping Beauty
6%
Ascites
6%
Cervical Intraepithelial Neoplasia
6%
Cancer Genes
6%
Single-cell RNA Sequencing (scRNA-seq)
6%
Gene Expression
6%
Melanoma Survivors
6%
Rwanda
6%
Histology
6%
Metastasis
6%
Chemoresistant
5%
Solid Tumors
5%